Douglas Williamson
Corporate Officer/Principal at The Royal College of Psychiatrists
Profile
Douglas J.
Williamson is currently a Member at The Royal College of Psychiatrists.
Previously, he held positions as an Independent Director at Bright Minds Biosciences, Inc. from 2022 to 2023, Head-Early Phase Clinical Development Neuroscience at Eli Lilly & Co., Vice President & Global Head-Therapeutic at PAREXEL International Corp., Senior VP, Head-US Research & Development at H.
Lundbeck A, Chief Medical Officer at Avadel Pharmaceuticals Plc, and Executive VP, Head-Research & Development at ACADIA Pharmaceuticals, Inc. He obtained a doctorate degree from The University of Edinburgh.
Douglas Williamson active positions
| Companies | Position | Start |
|---|---|---|
The Royal College of Psychiatrists
 The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Corporate Officer/Principal | - |
Former positions of Douglas Williamson
| Companies | Position | End |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Director/Board Member | 2023-01-08 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Training of Douglas Williamson
| The University of Edinburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Private companies | 2 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
The Royal College of Psychiatrists
The Royal College of Psychiatrists Financial ConglomeratesFinance The Royal College of Psychiatrists is a professional body responsible for education and training, and setting and raising standards in psychiatry. The non-profit company is based in London, UK. The British company provides a guide to suicide-related information and resources on their website, as well as special interest groups for members to come together in a particular area of psychiatry. The company also has a building capacity project funded by Health Education England and focus on quality improvement to improve the quality of care delivered to patients. The information they provide is for any woman who has - or thinks she may have - perinatal OCD, as well as partners, family, and friends who want to find out more. | Finance |
- Stock Market
- Insiders
- Douglas Williamson
